Inhibition of Tissue Plasminogen Activator Activity by Aspirin In Vivo and Its Relationship to Levels of Tissue Plasminogen Activator Antigen, Plasminogen Activator Inhibitor, and Their Complexes

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction.

  2009cited by this paper
• The Inhibitory Effect of Aspirin on Fibrinolysis Is Reversed by Iloprost, a Prostacyclin Analogue

  1989cited by this paper
• Plasminogen activator and plasminogen activator inhibitor activities in a reference population.

  1988cited by this paper
• Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay.

  1988cited by this paper
• Tissue Plasminogen Activator in Thrombolytic Therapy

  1987cited by this paper
• Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.

  1987cited by this paper
• Aspirin decreases fibrinolytic potential during venous occlusion, but not during acute physical activity.

  1987cited by this paper
• Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.

  1987cited by this paper
• Isolation of a new specific plasminogen activator in hibitor from pregnancy plasma

  1986cited by this paper
• Effect of thyroid hormones on plasma protein concentrations in man.

  1986cited by this paper
• Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells.

  1986cited by this paper
• Method for the determination of fast acting plasminogen activator inhibitor capacity (PAI-cap) in plasma, platelets and endothelial cells.

  1986cited by this paper
• Low dose aspirin does not prevent fibrinolytic response to venous occlusion.

  1986cited by this paper
• Blood Platelet Plasminogen Activator Inhibitor: Two Different Pools of Endothelial Cell Type Plasminogen Activator Inhibitor in Human Blood

  1986cited by this paper
• A Sensitive Assay, Specific for Endothelial Cell Type Plasminogen Activator Inhibitor in Blood Plasma

  1986cited by this paper
• Aspirin and venous occlusion: effects on blood fibrinolytic activity and tissue-type plasminogen activator levels.

  1986cited by this paper
• No significant effect of chronic aspirin use on fibrinolytic response to venous occlusion in coronary patients.

  1985cited by this paper
• Identification of a reversible inhibitor of plasminogen activators in blood plasma

  1985cited by this paper
• Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

  1985cited by this paper
• Immunoradiometric assay to measure the binding of a specific inhibitor to tissue-type plasminogen activator.

  1985cited by this paper
• Tissue plasminogen activator release in vivo in response to vasoactive agents.

  1985cited by this paper
• Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2.

  1985cited by this paper
• Aspirin, indomethacin and dazoxiben do not affect the fibrinolytic activation induced by venous occlusion.

  1985cited by this paper
• Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.

  1984cited by this paper
• Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity.

  1984cited by this paper
• Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells.

  1984cited by this paper
• Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina

  1984cited by this paper
• The Inability of Propranolol and Aspirin to Inhibit the Response of Fibrinolytic Activity and Factor VIII-Antigen to Infusion of DDAVP

  1984cited by this paper
• Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells.

  1983cited by this paper
• Evidence for a rapid inhibitor to tissue plasminogen activator in plasma.

  1983cited by this paper
• Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators.

  1983cited by this paper
• Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.

  1983cited by this paper
• Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex.

  1983cited by this paper
• An Enzyme Linked Immunosorbent Assay for Determination of Tissue Plasminogen Activator Applied to Patients with Thromboembolic Disease

  1983cited by this paper
• Exhaustion of arm fibrinolytic potential after repeated venous occlusions and local exercise.

  1982cited by this paper
• Effect of Prostacyclin on Fibrinolytic Activity in Patients with Arteriosclerosis Obliterans

  1982cited by this paper
• Stimulation of fibrinolytic activity in human skin fibroblasts by prostaglandins E1, E2 and I2.

  1982cited by this paper
• Studies on the haemostatic system in peripheral arterial disease. I. Factor VIII, fibrinolytic activity, and changes induced by venous occlusion and nicotinic acid administration.

  1981cited by this paper
• A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity.

  1981cited by this paper
• Treatment of pulmonary embolism with prostacyclin.

  1980cited by this paper
• On the Regulation and Control of Fibrinolysis

  1980cited by this paper
• Release of prostacyclin into the bloodstream and its exhaustion in humans after local blood flow changes (ischemia and venous stasis).

  1980cited by this paper
• Control of pulmonary fibrinolytic activity by prostaglandins.

  1979cited by this paper
• Determination of Aspirin, Salicylic Acid, Salicyluric Acid, and Gentisic Acid in Human Plasma and Urine by High Pressure Liquid Chromatography

  1979cited by this paper
• Production of a fibrinolytic inhibitor by cultured endothelial cells derived from human umbilical vein.

  1978cited by this paper
• Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.

  1977cited by this paper
• Acetylation of prostaglandin synthetase by aspirin. Purification and properties of the acetylated protein from sheep vesicular gland.

  1977cited by this paper
• Studies on the release of plasminogen activator.

  1976cited by this paper
• Absorption kinetics of aspirin in man following oral administration of an aqueous solution.

  1972cited by this paper
• Effect of Venous Occlusion on Coagulation and Fibrinolytic Components in Normal Subjects

  1968cited by this paper
• Urokinase Inhibitor in Human Placenta

  1968cited by this paper

• Effect of Low Dose Aspirin on Augmented Piasminogen Activator Inhibitor Type 1 Activity in Patients with Permanent Pacemakers

  1994cites this paper
• Baseline Fibrinolytic State and the Risk of Future Venous Thrombosis: A Prospective Study of Endogenous Tissue‐Type Plasminogen Activator and Plasminogen Activator Inhibitor

  1992cites this paper
• Aspirin in pregnancy

  1992cites this paper
• Stimulation of Plasmin Activity by Aspirin

  1991cites this paper